The thirdannual meeting of the ACT EU Multi-stakeholder platformwas held on 29 October 2025, with over 500 participants to explore how innovation can reshape clinical trials in Europe. The outcome report of the workshop is now available, summarising participants’ discussions on patient-centred research, methodologies, biotechnology, AI, digitalisation and ethics. Input from the meeting will inform the revision of the ACT EU workplan. Read the full report:ACT EU multi-stakeholder platform annual meeting report ACT EU'sMulti-stakeholder platformprovides a forum for clinical trials stakeholders and regulators to come together, exchange views and collaborate to improve the clinical trials environment for European patients and citizens.
ACT EU - Accelerating Clinical Trials · February 19, 2026
ACT EU Multi-stakeholder platform 2025 annual meeting report
Original title: Report from the 2025 Multi-stakeholder platform meeting
Report from the third annual ACT EU Multi-stakeholder platform meeting held 29 October 2025, summarising discussions on patient-centred research, methodologies, biotechnology, AI, digitalisation and ethics.
Published by ACT EU - Accelerating Clinical Trials. HealthSignal links to the original document; the summary above is extracted from the source text.